Comparison of the Clinical Performance of Refractive Rotationally Asymmetric Multifocal IOLs with Other Types of IOLs: A Meta-Analysis

Table 1

Characteristics of the studies (n = 9) included in the meta-analysis.

Study	Site	Design	Procedure	Included eyes: experimental group/control group	IOL in the experimental group	IOL in the control group	Newcastle-Ottawa scale scores	Follow-up (months)
Munoz et al. [6]	Spain	C	Cataract	40/40	Mplus LS-312 MF30	Acri.Lisa 366	Patient selection: 4; Comparability: 2; Outcome assessment: 3	6
Alio et al. [7]	Spain	C	Cataract	45/38	Mplus LS-312 MF30	Acri.Lisa 366	Patient selection: 2; Comparability: 2; Outcome assessment: 3	3
Alio et al. [8]	Spain	C	Cataract	26/31	Mplus LS-312 MF30	ReSTOR SN6AD3	Patient selection: 4; Comparability: 2; Outcome assessment: 2	3
Rosa et al. [9]	Portugal	C	Cataract	56/44	Mplus LS-312 MF30	ResSTOR SN6AD1	Patient selection: 4; Comparability:2; Outcome assessment: 3	3
Plaza et al. [10]	Spain	C	Cataract	30/30	Mplus LS-313 MF30	Acri.Smart 48S	Patient selection: 4; Comparability: 2; Outcome assessment: 3	3
Alio et al. [11]	Spain	C	Cataract	31/35	Mplus LS-312 MF15	Crystalens HD	Patient selection: 4; Comparability: 2; Outcome assessment: 3	3
Alio et al. [3, 12]	Spain	C	Cataract	24/28	Mplus LS-312 MF30	Acri.Smart 48S	Patient selection: 4; Comparability: 2; Outcome assessment: 3	3
Alfonso et al. [13]	Spain	C	Cataract	40/40	Mplus LS-312 MF30	ResSTOR SN6AD1	Patient selection: 4; Comparability: 2; Outcome assessment: 3	6
van der Linden et al. [14]	The Netherlands	C	RLE/cataract	90/143	Mplus LS-312 MF30	ResSTOR SN6AD1	Patient selection: 4; Comparability: 2; Outcome assessment: 3	3

C = comparative cohort trials; RLE = refractive lens change.